Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: A comprehensive economic evaluation using clinical trial and real-world evidence



McEwan, Phil, Bennett, Hayley, Khunti, Kamlesh, Wilding, John ORCID: 0000-0003-2839-8404, Edmonds, Christopher, Thuresson, Marcus, Wittbrodt, Eric, Fenici, Peter and Kosiborod, Mikhail
(2020) Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: A comprehensive economic evaluation using clinical trial and real-world evidence. DIABETES OBESITY & METABOLISM, 22 (12). 2364 - 2374.

[img] Text
McEwan SGLT2i revised submitted June 2020.docx - Accepted Version

Download (183kB)
Item Type: Article
Uncontrolled Keywords: cost-effectiveness, health economics, SGLT2 inhibitor, type 2 diabetes
Depositing User: Symplectic Admin
Date Deposited: 07 Oct 2020 09:17
Last Modified: 08 May 2021 17:10
DOI: 10.1111/dom.14162
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3101301